Current management of dyslipidemia final

55
CURRENT MANAGEMENT OF DYSLIPIDEMIA Dr Jayachandran Thejus MD DM Specialist Interventional Cardiologist Zulekha Hospital Sharjah

Transcript of Current management of dyslipidemia final

Page 1: Current management of dyslipidemia final

CURRENT MANAGEMENT OF DYSLIPIDEMIA

Dr Jayachandran Thejus MD DMSpecialist Interventional Cardiologist

Zulekha Hospital Sharjah

Page 2: Current management of dyslipidemia final

Part I

CURRENT MANAGEMENT OF DYSLIPIDEMIA- BASICS

Page 3: Current management of dyslipidemia final

How to interpret lipid profile result?• Total cholesterol• LDL• Triglyceride• HDL• VLDL

Page 4: Current management of dyslipidemia final

How to interpret lipid profile result?• Total cholesterol• LDL• Triglyceride• HDL• VLDL

Page 5: Current management of dyslipidemia final

How to interpret lipid profile result?• Total cholesterol• LDL• Triglyceride• HDL

• LDL- most important.• LDL measurement-– Direct– Indirect

Page 6: Current management of dyslipidemia final

How to interpret lipid profile result?• Total cholesterol• LDL• Triglyceride• HDL

• Prefer laboratories with direct LDL measurement.

• Request for “Fasting lipid profile- direct LDL estimate please”

Page 7: Current management of dyslipidemia final

How to interpret lipid profile result?• Total cholesterol• LDL• Triglyceride• HDL

• How to interpret LDL result?

Page 8: Current management of dyslipidemia final

Atherosclerotic disease

Any value of LDL is

high

Diabetes

LDL > 70 mg%

Others

LDL 190 mg% or more

or10 yr risk 5% or

more

What is high LDL?

Page 9: Current management of dyslipidemia final

http://cvdrisk.nhlbi.nih.gov/

Page 10: Current management of dyslipidemia final

http://cvdrisk.nhlbi.nih.gov/

Page 11: Current management of dyslipidemia final

http://cvdrisk.nhlbi.nih.gov/

Page 12: Current management of dyslipidemia final

http://cvdrisk.nhlbi.nih.gov/

Page 13: Current management of dyslipidemia final

Mobile app

Page 14: Current management of dyslipidemia final

Atherosclerotic disease

Start statin

Diabetes

Start statin if LDL is more

than 70 mg%

Others

Start statin if LDL 190 mg% or

moreor

10 yr risk 5% or more

Page 15: Current management of dyslipidemia final

Atherosclerotic disease

Start statin

Diabetes

Start statin unless LDL is less than 70

mg%

Others

Start statin if LDL 190 mg% or more

or10 yr risk 5% or more

High intensity statin

Moderate intensity statin

Page 16: Current management of dyslipidemia final

Statins• Atorvastatin• Rosuvastatin• Simvastatin• Pitavastatin• Fluvastatin

• 10 20 40 80 mg• 5 10 20 40 mg• 10 20 40 mg• Levazo 2mg 4 mg• Lescol-XL 80 mg

Page 17: Current management of dyslipidemia final

Statins• Atorvastatin• Rosuvastatin• Simvastatin• Pitavastatin• Fluvastatin

• 10 20 40 80 mg• 5 10 20 40 mg• 10 20 40 mg• Levazo 2mg 4 mg• Lescol-XL 80 mg

Page 18: Current management of dyslipidemia final

Before you start statin…• Check TSH.• Check SGPT.• Check CPK (total creatinine phosphokinase).• Check S creatinine, urine proteins.• Check HbA1C.

Page 19: Current management of dyslipidemia final

Before you start statin• Ensure adequate lifestyle changes- – Weight loss– Diet change– Exercise

• Avoid alcohol if SGPT is high.

Page 20: Current management of dyslipidemia final

How do you titrate statin dose?• Measure LDL initially every 6 weeks. Then at

more lengthy intervals.

Page 21: Current management of dyslipidemia final

Co-prescription with statin• With atorvastatin- avoid-– Verapamil, diltiazem, amlodipine, amiodarone– Grapefruit juice

• Rosuvastatin has less drug interactions.

Page 22: Current management of dyslipidemia final

Is repeat monitoring of SGPT & CPK needed?

• SGPT.• Muscle pain- do repeat CPK

Page 23: Current management of dyslipidemia final

When to stop statin?• No recommendation to stop.

Page 24: Current management of dyslipidemia final

Statin myopathy• Muscle pain• Increased CPK• Check for Vit D deficiency & hypothyroidism- correct• Atorvastatin (& simvastatin)- stop coexistent calcium channel

blockers and amiodarone.• Reduce dose of statin• Try alternate day therapy• Change from atorvastatin to rosuvastatin- low dose, alternate

day.• (Shift to fluvastatin)• Ezetimibe

Page 25: Current management of dyslipidemia final

Will statins produce diabetes?• Very low incidence (high dose therapy will

cause diabetes in 1 in 500 patients.)

Page 26: Current management of dyslipidemia final

Will statins cause cancer?• No

Page 27: Current management of dyslipidemia final

Will statins cause memory loss?• May cause. Conflicting data.• If a patient complains of memory loss or other

CNS symptom- prefer rosuvastatin to atorvastatin.

Page 28: Current management of dyslipidemia final

Will statins cause renal failure?• No.• (May cause benign proteinuria)

Page 29: Current management of dyslipidemia final

Ezetimibe • Decreases LDL• 10 mg OD • Cholesterol absorption inhibitor• SGPT elevation• Add to statin/ alternative to statin.

Page 30: Current management of dyslipidemia final

PCSK9 inhibitor • Alirocumab (Praluent)• Self S/C injection every 2 weeks (75/150 mg)• For very high LDL (familial dyslipidemias).

Page 31: Current management of dyslipidemia final

Triglycerides• More than 150 mg% is abnormal.• More than 200 mg%- CAD.• More than 500- 800mg%- pancreatitis.

Page 32: Current management of dyslipidemia final

• Secondary causes-– Obesity– Diabetes mellitus– Alcohol intake– Nephrotic syndrome– Hypothyroidism– Estrogen replacement therapy– Beta blocker– Steroid– Familial

Page 33: Current management of dyslipidemia final

• 200 to 500 mg%-– Most important- address secondary cause.– Aim of treatment is reduction of CAD risk, not reduction of

pancreatitis risk– Treat only if patient is otherwise a candidate for statin based on LDL

guidelines– Statin alone

• More than 500 mg%-– Aim of treatment is reduction of pancreatitis risk.– Fenofibrate 145 mg– Omega 3 fatty acids– Rosuvastatin 5-10 mg may be added to fenofibrate

Page 34: Current management of dyslipidemia final

Low HDL• Definition– < 40 mg % in men– < 50 mg % in women

• Lifestyle changes-– Exercise– Weight loss– Smoking cessation

• No specific drug treatment is indicated.

Page 35: Current management of dyslipidemia final

Take home messages• LDL more than 70 mg% in diabetics & any LDL

in CAD patients needs to be treated.• LDL 190 mg % or more in others needs to be

treated. • If LDL is less than 190 mg %, find 10 year

cardiac risk and treat if it is more than 5%.• Statin is preferred.

Page 36: Current management of dyslipidemia final

Take home messages• Take SGPT & CPK before treatment.• For hypertriglyceridemia more than 500 mg %

fenofibrate or omega 3.• Low HDL alone does not need treatment.

Page 37: Current management of dyslipidemia final

END OF PART 1

Page 38: Current management of dyslipidemia final

Part II

CURRENT MANAGEMENT OF DYSLIPIDEMIA- ADVANCED

Page 39: Current management of dyslipidemia final

CKD• Automatically qualify for statin Rx- similar to

atherosclerotic disease• In dialysis dependent persons, statins are not

indicated.

Page 40: Current management of dyslipidemia final

Treatment goalCondition Targets (both should be met)

Atherosclerotic disease LDL < 70 mg/dL and 50% reduction in LDL

Diabetes LDL < 70 mg/dL and 50% reduction in LDL

CKD LDL < 70 mg/dL and 50% reduction in LDL

Others

LDL > 190 mg/dL LDL < 100 mg/dL and 50% reduction in LDL

LDL < 190 mg/dL, but 10 yr risk > 5% LDL < 115 mg/dL and 30% reduction in LDL

After LDL goal is met, non HDL goal should be met- goal is 30 mg% + LDL goal.

Page 41: Current management of dyslipidemia final

Risk scores• ACC/AHA- Pooled cohort equation• ESC- SCORE system- HDL is also taken into

account

Page 42: Current management of dyslipidemia final

SCORE system- very useful relative risk estimator- can be shown to patient

Page 43: Current management of dyslipidemia final

Young (age < 40 yrs)• Statin for primary prevention is only for 40

years or more unless LDL is very high (>190mg%).

• Younger patients- take decision in individual case.

Page 44: Current management of dyslipidemia final

Old (> 75 yrs)• Scoring systems overestimate risk in elderly• After age 75 years, statin side effects are

more- lower dose is advised- also titration up is advised

Page 45: Current management of dyslipidemia final

Lipid profile- fasting or not?• First test- always fasting• Further tests- if TG is not a concern, non

fasting is enough, except in diabetics.

Page 46: Current management of dyslipidemia final

Statin adherence• Surprisingly low in monitored studies• If LDL goal is not achieved, maintain a drug

diary cross checked by a family member.

Page 47: Current management of dyslipidemia final

Lp (a)• Lp (a) is genetically determined. • Values more than 50 mg/dL increase risk of

CAD.

Page 48: Current management of dyslipidemia final

Fibrates• Monitor CPK when giving with statin.• If statin is co-prescribed, rosuvastatin at low dose

(5-10 mg).• Liver enzyme elevation can occur-monitor SGPT• Pancreatitis risk increases when given for

moderate TG- so avoid if TG less than 500 mg%• DVT may occur- watch. • Creatinine may increase- monitor frequently

during treatment.

Page 49: Current management of dyslipidemia final

Omega 3 fatty acids• 1 gm capsule• Dose- 3 capsules daily with meals• Risk of bleeding, especially with antiplatelets

Page 50: Current management of dyslipidemia final

Pregnancy and lactation• Avoid statins during pregnancy and lactation• In ladies of child bearing age, preferably avoid

statin- if needed, avoid pregnancy.• Phytosterol tabs, isphagula powder.• OC should be avoided if LDL > 160 mg%

Page 51: Current management of dyslipidemia final

Alcohol in dyslipidemia• High TG- avoid alcohol• Statin given to patient with elevated SGPT-

avoid alcohol• CAD protection from low alcohol consumption

is only for Western population- not for South Asians

Page 52: Current management of dyslipidemia final

Familial dyslipidemia• LDL more than 190 mg % is a strong indicator• Screen all first degree relatives (cascade

screening) • Age from 5 yrs onwards

Page 53: Current management of dyslipidemia final

Type 1 DM• Supernormal lipid profile- deceptive• In spite of normal LDL, give statin if – Renal disease or– Microalbuminuria

Page 54: Current management of dyslipidemia final

Statins are not needed solely for• HF of non ischemic cause• Aortic stenosis• (Statins are useful for abdominal aortic

aneurysm)

Page 55: Current management of dyslipidemia final

End of Part II

Thank you